Kidney drug study: how AZD5462 behaves in impaired kidneys
NCT ID NCT06661733
First seen Jan 05, 2026 · Last updated May 20, 2026 · Updated 22 times
Summary
This study looked at how the drug AZD5462 moves through the body in people with kidney problems compared to healthy volunteers. Sixteen adults took a single dose, and researchers measured drug levels and checked for side effects. The goal was to understand how kidney function affects the drug, not to treat the kidney disease itself.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RENAL IMPAIRMENT are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Research Site
Sofia, 1612, Bulgaria
Conditions
Explore the condition pages connected to this study.